Hepatic Resection Versus Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: A Cohort Study

BACKGROUND: The selection criteria for hepatic resection (HR) in intermediate-stage (IM) hepatocellular carcinoma (HCC) are still controversial. We used real-world data to evaluate the overall survival (OS) in treatment with HR or transarterial chemoembolization (TACE). METHODS: In total, 942 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Linbin, Zheng, Peichan, Wu, Zhixian, Chen, Xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579001/
https://www.ncbi.nlm.nih.gov/pubmed/34778022
http://dx.doi.org/10.3389/fonc.2021.618937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579001/
https://www.ncbi.nlm.nih.gov/pubmed/34778022
http://dx.doi.org/10.3389/fonc.2021.618937

Ejemplares similares